作者:青峰医药集团
发表时间:2025-01-06 00:00
青峰医药将于2025年1月13日至16日参加在旧金山举行的“第 43 届摩根大通医疗健康大会”。青峰医药希望与全球潜在的合作伙伴举行面对面商谈，探讨创新产品的国际授权和引进合作。
Qingfeng Pharmaceutical Group, will attend “The 43rd Annual J.P. Morgan Healthcare Conference” in San Francisco, from January 13-16, 2025. Qingfeng would like to hold one-on-one meetings with potential global partners to explore international cooperation on out/in license of innovative drugs.
摩根大通医疗健康大会（J.P. Morgan Healthcare Conference）是全球规模最大、最具影响力的医疗投资研讨会之一?，每年1月在美国旧金山举行。
J.P. Morgan Healthcare Conference is one of the world's largest and most influential healthcare investment seminars ? and is held every January in San Francisco, USA.
该大会汇聚了全球医药和生物科技企业高层、创新企业家及投融资专家，共同探讨行业前沿趋势和合作机遇。
The conference brings together high-level pharmaceutical and biotechnology enterprises, innovative entrepreneurs and investment and financing experts from around the world to discuss the frontier trends and cooperation opportunities.
第43届摩根大通医疗健康大会将于2025年1月13日至16日举行，重点聚焦医药创新、并购趋势及国际化合作?。大会将继续作为生物医药和生命科学领域的重要风向标，推动行业的创新和发展。
The 43rd J.P. Morgan Healthcare Conference will be held from January 13-16, 2025 and will focus on pharmaceutical innovation, M&A trends and international collaborations.The conference will continue to serve as an important weathervane in the field of biomedicine and life science to promote industry innovation and development.
